Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
Brunsvig, Paal F., Guren, Tormod Kyrre, Nyakas, Marta, Steinfeldt-Reisse, Claudius H., Rasch, Wenche, Kyte, Jon Amund, Juul, Hedvig Vidarsdotter, Aamdal, Steinar, Gaudernack, Gustav, Inderberg, Else MVolume:
11
Journal:
Frontiers in Immunology
DOI:
10.3389/fimmu.2020.572172
Date:
November, 2020
Fichier:
PDF, 1.12 MB
2020
File converter
Plus de résultats de recherche
More benefits 
